Squarepoint’s Akero Therapeutics AKRO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.36M | Sell |
25,447
-15,214
| -37% | -$812K | ﹤0.01% | 1351 |
|
|
2025
Q1 | $1.65M | Buy |
+40,661
| New | +$1.65M | ﹤0.01% | 1265 |
|
|
2024
Q2 | – | Sell |
-7,997
| Closed | -$202K | – | 2452 |
|
|
2024
Q1 | $202K | Sell |
7,997
-67,152
| -89% | -$1.7M | ﹤0.01% | 2093 |
|
|
2023
Q4 | $1.75M | Buy |
75,149
+39,558
| +111% | +$924K | ﹤0.01% | 1090 |
|
|
2023
Q3 | $1.8M | Buy |
+35,591
| New | +$1.8M | ﹤0.01% | 1019 |
|
|
2023
Q2 | – | Sell |
-20,091
| Closed | -$769K | – | 2364 |
|
|
2023
Q1 | $769K | Sell |
20,091
-6,945
| -26% | -$266K | ﹤0.01% | 1288 |
|
|
2022
Q4 | $1.48M | Buy |
+27,036
| New | +$1.48M | 0.01% | 914 |
|
|
2021
Q1 | – | Sell |
-39,815
| Closed | -$1.03M | – | 2511 |
|
|
2020
Q4 | $1.03M | Buy |
39,815
+29,830
| +299% | +$769K | 0.01% | 1059 |
|
|
2020
Q3 | $307K | Sell |
9,985
-5,103
| -34% | -$157K | ﹤0.01% | 1660 |
|
|
2020
Q2 | $376K | Sell |
15,088
-4,310
| -22% | -$107K | 0.01% | 1442 |
|
|
2020
Q1 | $411K | Sell |
19,398
-39,110
| -67% | -$829K | 0.01% | 1137 |
|
|
2019
Q4 | $1.3M | Buy |
58,508
+39,634
| +210% | +$880K | 0.01% | 1150 |
|
|
2019
Q3 | $429K | Buy |
+18,874
| New | +$429K | ﹤0.01% | 1636 |
|